Zacks Rating on C.R. Bard (BCR)

C.R. Bard (BCR) : 1 brokerage houses believe that C.R. Bard (BCR) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 12 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on C.R. Bard (BCR). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 14 Wall Street Analysts endorse the stock as a Hold with a rating of 2.79.

C.R. Bard (BCR) has been rated by 9 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $264 and the lowest price target forecast is $220. The average forecast of all the analysts is $241 and the expected standard deviation is $12.5.


CR Bard Inc. has lost 0.5% in the last five trading days and dropped 4.93% in the last 4 weeks. CR Bard Inc. has dropped 1.52% during the last 3-month period . Year-to-Date the stock performance stands at 15.32%. C.R. Bard (NYSE:BCR): On Tuesdays trading session , Opening price of the stock was $218 with an intraday high of $220.29. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $217.43. However, the stock managed to close at $217.68, a loss of 0.13% for the day. On the previous day, the stock had closed at $217.97. The total traded volume of the day was 428,632 shares.

C. R. Bard, Inc. (Bard) and its subsidiaries are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs, in addition to hemostats and surgical sealants.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.